Journal
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Volume 80, Issue 3, Pages 670-+Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.jaad.2018.08.052
Keywords
CMV reactivation; disease severity; drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS); prognosis; scoring system
Categories
Funding
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare, Japan
Ask authors/readers for more resources
Background: The prognosis of drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) is highly unpredictable. Severe complications, either related or unrelated to cytomegalovirus (CMV) reactivation, are a highly probable cause of death. Objectives: The aim was to establish a scoring system for DiHS/DRESS that can be used to monitor severity, predict prognosis, and stratify the risk of developing CMV disease and complications. Methods: A retrospective analysis of 55 patients with DiHS/DRESS was performed. A composite score was created using clinical data. DiHS/DRESS patients were also stratified into 3 groups based on the scores to predict the risk of CMV reactivation and complications. Results: This scoring system made it possible to predict CMV disease and complications. Scores >= 4 were associated with the later development of CMV disease and complications, while no patients with scores >= 4 developed complications. Limitations: This was a single-institution study with a relatively small patient cohort that lacked a validation cohort. Conclusions: Our scoring system may be useful for predicting CMV-related complications, and early intervention with anti-CMV agents should be considered in patients with scores >= 4 or with evidence of CMV reactivation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available